科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Journal of patient-reported outcomes2026-09-19

When do we need to take action? Cut-off values for the hamburg inventory for measuring quality of life in oncological patients (HELP-6).

Theresa Schrage, Mirja Görlach, Christian Stephan Betz, Carsten Bokemeyer, Nicolaus Kroeger, Volkmar Mueller, Andreas Krüll, Holger Schulz, Christiane Bleich

一句话结论 · In one sentence

By applying the HELP-6 with the cut-off values established in this study, clinicians can more readily interpret patients' HrQoL, thereby supporting effective clinical decision-making. This feature is especially valuable in routine care, where streamlined monitoring of patient quality of life is paramount. Further conceptualization and validation of the Dignity scale, as well as its integration into patient-reported outcome measures, are warranted.

原始摘要(英文原文)· Original abstract
PURPOSE: Results of patient-reported outcome measurements need to be comprehensible and conclusive for a successful integration into treatment in cancer care. The aim of this study was to determine cut-off values for the recently developed "Hamburg Inventory for Measuring Quality of Life in Oncological Patients-6" (HELP-6), a short measurement for Health-related Quality of Life (HrQoL) in routine care in oncological patients. METHODS: Oncological in- and out-patients with differing cancer entities participated in this study. The survey included the HELP-6 and standardized questionnaires (Distress-Thermometer, PHQ-4, Fact-G, PDI-G). Six receiver operating characteristics analyses were performed, one for each scale of the instrument (Emotional Health, Physical Ailment, Social Functionality, Autonomy, Dignity, Resources). RESULTS: For five of the six scales cut-offs could be determined. Areas under the Curve were between 0.7 and 0.8. However, the Dignity scale demonstrated poor discriminative validity, failing to distinguish adequately between severity levels of patient groups. CONCLUSION: By applying the HELP-6 with the cut-off values established in this study, clinicians can more readily interpret patients' HrQoL, thereby supporting effective clinical decision-making. This feature is especially valuable in routine care, where streamlined monitoring of patient quality of life is paramount. Further conceptualization and validation of the Dignity scale, as well as its integration into patient-reported outcome measures, are warranted. TRIAL REGISTRATION: The complete study including the development of the instrument was registered at Open Science Framework ***redacted for peer-review***. CLINICAL TRIAL NUMBER: not applicable.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

When do we need to take action? Cut-off values for the hamburg inventory for measuring quality of life in oncological patients (HELP-6). — 科研速览 Science Skim